Press releases
Fire brought under control at our site in Chasse-sur-Rhône: no injury or damage
A fire broke out this morning around 4:20 am outside of a small production workshop at our site in Chasse-sur-Rhône.
Novasep launches oXYgene™, a fully integrated offer for boosting viral vector production
Leveraging on its recent investments Senrise-IV and Senefill, Novasep launches a unique
2-year turnkey plant offer to accelerate commercial production of viral vectors.
Senefill, Novasep's commercial facility for aseptic filling and finishing operations, is now ready to operate.
Senefill will be commissioned on October 1, 2019 and will offer Fill & Finish clinical and commercial services for biological products, from formulation to packaging.
NOVASEP and THERAVECTYS enter into a new license agreement on DNA Flap Technology for GMP Manufacturing of lentiviral vectors
This agreement supports the growing demand for lentivector-based gene therapies, immunotherapies and vaccines
Novasep announces the success of its consent solicitation extending the maturity of its notes
• All resolutions were approved by 100% of the participating Noteholders and C Warrantholders
• Noteholders representing 99.9% of total outstanding principal amount participated
Enzene Biosciences chooses Novasep BioSC® Pilot chromatography for its automated end to end continuous manufacture of mAb.
Novasep, a leading supplier of services and technologies for the life sciences industry, announces Enzene Biosciences (India) has chosen BioSC® Pilot for purification of biopharmaceuticals to operate in its Pune plant.
Novasep announces the launch of a consent solicitation for the maturity extension of notes with requisite voting majority of the noteholders already secured
Novasep Holding S.A.S (“Novasep”), a leading supplier of services and technologies for the life sciences industry, announces the launch of a consent solicitation (the “Consent Solicitation”) in order to, inter alia:
Novasep industrializes potato protein purification unit for Solanic B.V.
This represents a step forward for the plant-based protein purification industry, with the first compact bed chromatography system for the purification of vegetable proteins.
Novasep opens €27m new Viral Vector Commercial Production Facility
With this new Viral Vector bioproduction facility, Novasep confirms its leadership position and effectively addresses the growing gene therapy market demand
Novasep Custom Manufacturing Site Passes Fifth Consecutive FDA Inspection Without 483s
Novasep’s robust quality assurance system, fully compliant with the highest world standards, showcased during successful FDA inspection of the Chasse-sur-Rhône (France) facility.